首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >In Vitro Activity of the Aminoglycoside Antibiotic Arbekacin against Acinetobacter baumannii-calcoaceticus Isolated from War-Wounded Patients at Walter Reed Army Medical Center
【2h】

In Vitro Activity of the Aminoglycoside Antibiotic Arbekacin against Acinetobacter baumannii-calcoaceticus Isolated from War-Wounded Patients at Walter Reed Army Medical Center

机译:瓦尔特·里德陆军医疗中心的氨基糖苷类抗生素阿贝卡星对战伤患者分离的鲍曼不动杆菌醋酸钙的体外活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We determined the in vitro MIC of arbekacin against 200 Acinetobacter isolates recovered from wounded soldiers. The median MIC was 2 μg/ml (range, 0.5 to >64 μg/ml). A total of 97.5% of the isolates had arbekacin MICs of <8 μg/ml and 86.5% had MICs of ≤4 μg/ml. There was no association between the arbekacin MIC and susceptibility to 16 other antibiotics or the specimen source (P = 0.7239). Synergy testing suggested an enhanced effect of arbekacin-carbapenem combinations.
机译:我们确定了从受伤士兵中回收的200株不动杆菌的阿贝卡星的体外MIC。中位数MIC为2μg/ ml(范围为0.5至> 64μg/ ml)。分离株总数的97.5%的阿贝卡星MIC≤8μg/ ml,86.5%的MIC≤4μg/ ml。阿贝卡星MIC与对其他16种抗生素或标本来源的敏感性之间没有关联(P = 0.7239)。协同测试表明,阿贝卡星-卡巴培南组合的作用增强。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号